2017 American Transplant Congress
Outcome of Living Donor Transplantation in Pediatric Recipients Over the Last Three Decades by Era: An Analysis of UNOS Database.
Surgery, State University New York, Syracuse, NY
Background: Living donor is the potential solution to organ shortage. This retrospective analysis of UNOS database evaluates the outcome of living donor transplantation across 4…2017 American Transplant Congress
The Effect of the Procurement Surgeon on Transplanted Abdominal Organ Outcomes: An OPTN/SRTR Analysis to Evaluate Regional Organ Procurement Collaboration.
OBJECTIVE: A number of single center studies have demonstrated utility of regional organ procurement collaboration to reduce travel redundancy by procuring surgical teams with no…2017 American Transplant Congress
Is There an Association Between Number of Outpatient Primary Care Visits (OPV) and Outcomes in Kidney Transplantation (KTP)?
Background: Periodic outpatient primary care visits (PCV) after KTP is recommended to achieve optimal outcomes, but annual rates of PCV by KTP recipients is not…2017 American Transplant Congress
Emerging Safety and Tolerability of Obinutuzumab, a Type 2 Anti-CD20 Monoclonal Antibody for the Desensitization of Renal Transplant Candidates.
Background: Rituximab has limited efficacy for desensitizing allosensitized patients (pts) with end-stage renal disease (ESRD) and enabling kidney transplantation (KTx), however, tissue B-cell depletion is…2017 American Transplant Congress
DSA Presence Does Not Affect Renal Histology and Clinical Outcome in Chronic Active Antibody Mediated Rejection.
1Erasmus MC, Rotterdam, Netherlands; 2Leiden UMC, Leiden, Netherlands
Introduction. Chronic active antibody mediated rejection (caABMR) is a major cause of long term renal allograft dysfunction. It is defined by the presence of microvascular…2017 American Transplant Congress
Comparing Outcomes of ABO Incompatible to DSA Positive/CDC-AHG Negative Kidney Transplantation.
Back ground: Desensitization provides benefit in high risk kidney transplant recipients. We evaluated one year outcomes, including substances removal by apheresis techniques of ABO incompatible…2017 American Transplant Congress
Outcomes of Deceased Donor Kidney Transplantation in Elderly Recipients Aged 70 Years and Older.
Introduction: The number of patients aged 70 years and older receiving renal replacement therapy is increasing. There is uncertainty regarding whether listing for deceased donor…2017 American Transplant Congress
Assessment of Donor-Reactive T-Cell Immunity by the Novel Urine Cell-Derived Alloantigen Assay Allows Prediction of Acute Rejection in Renal Transplant Patients.
Presensitization and donor-specific immunity play a major role in acute and chronic rejection of kidney transplant patients. While assessment of humoral sensitization is well standardised…2017 American Transplant Congress
Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes.
Background: Bloodstream infections or bacteremia is a serious complication after kidney transplantation. The incidence, risk factors, and outcomes of bacteremia among kidney transplant recipients have…2017 American Transplant Congress
Incidence and Risk Factors for Cervical Dysplasia Associated to Human Papillomavirus Infection in Women with Kidney Transplant.
Introduction: Women with kidney transplant (KT) have an increased risk for Human Papillomavirus (HPV) infection, which is related to cervical cancer, reaching an incidence of…
- « Previous Page
- 1
- …
- 340
- 341
- 342
- 343
- 344
- …
- 531
- Next Page »